How It Started

Accelerating Research to Save Lives

The Prostate Cancer Foundation® (PCF™) is the world’s leading philanthropic organization dedicated to funding
life-saving prostate cancer research. Founded in 1993 by Mike Milken, PCF has raised more than $1 billion to fund
cutting-edge research through more than 2,615 research projects at 312 leading cancer centers, with a global
footprint spanning 29 countries. Since PCF’s inception, and through its efforts, patients around the world are
living longer, suffering fewer complications, and enjoying better quality of life. PCF is committed to the mission of
ending death and suffering from this disease.

30 Years of Impact

In 1993, prostate cancer research was underfunded, awareness was low, and collaboration among researchers was limited. Determined to change this, Milken founded the Prostate Cancer Foundation (formerly known as CaP CURE) with a mission to accelerate research, simplify grant processes, and advance understanding of prostate cancer.

A Catalyst for Change

The Prostate Cancer Foundation (PCF), originally founded as CaP CURE, set out to transform prostate cancer research and treatment. At the time, the PSA screening test was new, there were only three drugs for advanced disease, and the outlook for metastatic prostate cancer was bleak. PCF pioneered a new funding model, becoming a catalyst for change.

PCF’s Approach

Today, PCF fosters unity and progress through scientific, human, and social investments, leading to more effective treatment options for patients, and hope for a future beyond their diagnosis.

Invest in People

Invest in Community

Invest in Science